http://asiapharmaceutics.info/index.php/ajp/issue/feed Asian Journal of Pharmaceutics (AJP) 2026-01-23T06:39:36+00:00 M.A. Naidu editor@asiapharmaceutics.info Open Journal Systems <p style="text-align: justify;"><strong>Asian Journal of Pharmaceutics</strong> is an international Referred and Peer Reviewed Online and print Journal with E-ISSN: <strong>1998-409X </strong>and P-ISSN: <strong>0973-8398 </strong>published by<strong> B R Nahata Smriti Sansthan </strong>for the enhancement of research and extension in Pharmaceutics. AJP is an open access online Journal, that publishes full-length papers, reviews and short communications exploring and to promote diverse and integrated areas of Pharmaceutics and Pharmaceutical Technology, Formulation Design and Development, Drug Discovery and Development Interface, Manufacturing Science and Engineering, Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Clinical Pharmacology, General Medicine and Translational Research, Physical Pharmacy and Biopharmaceutics, Novel Drug delivery system, Biotechnology &amp; Microbiological evaluations, Regulatory Sciences. AJP is steered by a distinguished Board of Editors. To maintain a high-quality journal, manuscripts that appear in the AJP Articles section have been subjected to a rigorous review process.</p> <p><strong><u>JOURNAL PARTICULARS</u></strong></p> <table> <tbody> <tr> <td width="281"> <p>Title</p> </td> <td width="517"> <p>Asian Journal of Pharmaceutics</p> </td> </tr> <tr> <td width="281"> <p>Frequency</p> </td> <td width="517"> <p>Quarterly</p> </td> </tr> <tr> <td width="281"> <p>E- ISSN</p> </td> <td width="517"> <p><strong>1998-409X</strong></p> </td> </tr> <tr> <td width="281"> <p>P-ISSN</p> </td> <td width="517"> <p><strong>0973-8398</strong></p> </td> </tr> <tr> <td width="281"> <p>DOI</p> </td> <td width="517"> <p><strong>https://doi.org/10.22377/ajp.v10i04</strong></p> </td> </tr> <tr> <td width="281"> <p>Publisher</p> </td> <td width="517"> <p><strong>Mr. Narendra Nahata</strong>, B.R. Nahata College of Pharmacy, Mhow-Neemuch Road, Mandsaur-458001, Madhya Pradesh</p> </td> </tr> <tr> <td width="281"> <p>Chief Editor</p> </td> <td width="517"> <p>Dr. M.A. Naidu</p> </td> </tr> <tr> <td width="281"> <p>Starting Year</p> </td> <td width="517"> <p>2007</p> </td> </tr> <tr> <td width="281"> <p>Subject</p> </td> <td width="517"> <p>Pharmacy subjects</p> </td> </tr> <tr> <td width="281"> <p>Language</p> </td> <td width="517"> <p>English Language</p> </td> </tr> <tr> <td width="281"> <p>Publication Format</p> </td> <td width="517"> <p>Online and Print [Both]</p> </td> </tr> <tr> <td width="281"> <p>Email Id</p> </td> <td width="517"> <p><a href="mailto:editor@asiapharmaceutics.info">editor@asiapharmaceutics.info</a>,editor@brnsspublicationhub.org</p> </td> </tr> <tr> <td width="281"> <p>Mobile No.</p> </td> <td width="517"> <p>+91-7049737901</p> </td> </tr> <tr> <td width="281"> <p>Website</p> </td> <td width="517"> <p>www.asiapharmaceutics.info</p> </td> </tr> <tr> <td width="281"> <p>Address</p> </td> <td width="517"> <p>B.R. Nahata Smriti Sansthan, BRNSS PUBLICATION HUB, B.R. Nahata College of Pharmacy, Mhow-Neemuch Road, Mandsaur-458001, Madhya Pradesh</p> </td> </tr> </tbody> </table> <p> </p> http://asiapharmaceutics.info/index.php/ajp/article/view/7008 Rifampicin-Loaded Nanoparticles for Targeted Tuberculosis Therapy: Enhancing Delivery and Efficacy 2026-01-10T14:21:27+00:00 Mohd Imran imran.pchem@gmail.com <p>Tuberculosis (TB) remains a major global health challenge, with limitations in the present drug regimens, including</p> <p>poor bioavailability, systemic side effects, and the emergence of multidrug resistance. Rifampicin (RMP), a firstline anti-TB drug, suffers from rapid metabolism, limited tissue penetration, and poor targeting, necessitating</p> <p>frequent dosing. Nanoparticle-based drug delivery systems offer a promising strategy to address these challenges</p> <p>by enhancing targeted delivery, reducing toxicity, and improving therapeutic efficacy. A disruptive solution</p> <p>to these challenges is presented by nanotechnology-based drug delivery systems. In this review, we examine</p> <p>various studies on RMP-loaded nanoparticles, including polymeric nanoparticles, lipid-based nanocarriers (such</p> <p>as liposomes and solid lipid nanoparticles), metallic nanoparticles, dendrimers, and micelles. These carriers</p> <p>enhance the stability of the drug, facilitate its controlled release, and target its delivery to TB-infected tissues and</p> <p>macrophages. Nanocarriers loaded with RMP have a high potential for transforming TB treatment because they</p> <p>are more effective, have fewer systemic adverse effects, and are part of combating TB drug resistance on a global</p> <p>scale.</p> 2025-01-10T00:00:00+00:00 Copyright (c) 2026 Mohd Imran http://asiapharmaceutics.info/index.php/ajp/article/view/7039 Fixed-Dose Combination Therapy in Hypertension: A Systematic Review of Efficacy, Adherence, and Cardiovascular Outcomes 2026-01-23T06:33:02+00:00 Dr. Mohd Imran imran.pchem@gmail.com <p>Hypertension remains a leading contributor to global cardiovascular morbidity and mortality. Despite the <br>availability of effective pharmacological treatments, optimal blood pressure (BP) control continues to be suboptimal <br>in many populations, mainly due to poor medication adherence. Fixed-dose combination (FDC) therapies, which <br>incorporate two or more antihypertensive agents into a single formulation, have been proposed as a strategy to <br>enhance adherence and improve clinical outcomes. This systematic review aimed to assess the effectiveness, <br>safety, compliance, and cost-effectiveness of FDC antihypertensive therapies in comparison to monotherapy or <br>free-pill combinations in adults diagnosed with primary hypertension. A comprehensive search of the PubMed, <br>Cochrane Library, and Scopus databases was conducted for studies published between January 2020 and June <br>2025. Eligible studies included randomized controlled trials and observational studies that reported at least one <br>relevant clinical outcome, such as changes in BP, adherence levels, cardiovascular event incidence, safety profiles, <br>or economic impact. Twenty-eight studies met the inclusion criteria, representing a range of populations and <br>healthcare settings. The findings consistently indicated that FDC therapies were associated with greater reductions <br>in both systolic and diastolic BP, improved treatment adherence, and comparable or superior safety outcomes <br>relative to conventional therapeutic regimens. The methodological quality of the included studies was generally <br>high, with most trials assessed as having low risk of bias and observational studies rated as moderate-to-high <br>quality. Moreover, several studies highlighted the potential economic benefits of FDCs, including reduced pill <br>burden and enhanced treatment efficiency. Collectively, the evidence supports the broader adoption of FDCs as <br>an effective, safe, and scalable approach for the management of hypertension, particularly in resource-constrained <br>settings and among high-risk patient groups.</p> 2026-01-23T00:00:00+00:00 Copyright (c) 2026 Dr. Mohd Imran http://asiapharmaceutics.info/index.php/ajp/article/view/7040 Therapeutic Approaches in Adult Orthodontic-Restorative Patients with Dental Anomalies: A Narrative Review 2026-01-23T06:39:36+00:00 Felwa Sulaiman AlHudaithi felwa.alhudaithi@riyadh.edu.sa <p>This narrative review (2023–2025) summarizes the treatment of adult orthodontic-restorative patients with different <br>dental anomalies, such as hypodontia, microdontia, or enamel anomaly. It is, therefore, extremely important to <br>have an interdisciplinary and digitally guided approach while managing adult dental anomalies. Digital dentistry, <br>supported by cone beam computed tomography, computer-aided design/computer-aided manufacturing, and <br>Digital Smile Design, enables diagnosis, treatment planning, as well as the interdisciplinary approach to be more <br>effectively realized. Research comparing clear aligners and fixed appliances revealed that although the results <br>regarding alignment are similar between the two systems, clear aligners are more comfortable to wear, easier <br>to maintain, and cleaner, as well as esthetically pleasing. Fixed appliances are still critical for mainly severe <br>malocclusions that need to be treated. In restoring teeth using ceramic veneer bonding to crowns on enamel, the <br>survival rate is above 90%, whereas composite bonded crowns fail readily. The existing technique is thereby <br>shifted by present restorative techniques toward the preservation of enamel and minimally invasive techniques <br>using bioactive materials. Orthodontic alignment in combination with restorative excellence offers digital control <br>over the predicted function and esthetics of a case. It is, therefore, extremely important to have an interdisciplinary <br>and digitally guided approach while managing adult dental anomalies.</p> 2026-01-23T00:00:00+00:00 Copyright (c) 2026 Felwa Sulaiman AlHudaithi